PT-141
$150.00
Sale price
$150.00
Regular price
Skip to product information
PT-141 (Bremelanotide) is a synthetic analogue of alpha-MSH that acts as a melanocortin receptor agonist. Unlike traditional approaches, it works centrally through the nervous system rather than the vascular system. It is FDA-approved as Vyleesi for hypoactive sexual desire disorder and is widely studied for its role in sexual function research.
Key Benefits:
• Central nervous system activation
• Melanocortin receptor agonism
• Sexual function research
• FDA-studied compound
• Neurological pathway modulation
PT-141
$150.00
Sale price
$150.00
Regular price
Key Benefits:
• Central nervous system activation
• Melanocortin receptor agonism
• Sexual function research
• FDA-studied compound
• Neurological pathway modulation